Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Background: Three-dimensional echocardiographic image for atrial septal defect (ASD) is useful for evaluation of defect size and shape. The investigators suggested optimal device size using three-dimensional transesophageal echocardiographic image and our formula in previous study. Purpose: In this study, the investigators seek to predict the correct device size and confirm the accuracy of the formula that we made before device closure in ASD patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Age ≥18 year-old

• Susceptible indication for atrial septal defect closure

• Potential candidate for device closure

Locations
Other Locations
Republic of Korea
Asan Medical Center
RECRUITING
Seoul
Contact Information
Primary
Jong-Min Song, MD,PhD
jmsong@amc.seoul.kr
+82-2-3010-3168
Time Frame
Start Date: 2014-03
Estimated Completion Date: 2026-12
Participants
Target number of participants: 100
Treatments
Experimental: transcatheter device closure
Choosing device size using three dimensional image and the formula without sizing balloon
Related Therapeutic Areas
Sponsors
Leads: Asan Medical Center

This content was sourced from clinicaltrials.gov